Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Luttmann

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Molecular Pharmacology|September 25, 1999
Endothelin B receptor modulates inflammatory pain and cutaneous inflammationD E Griswold, S A Douglas, L D Martin, et al.
European Journal of Pharmacology|February 28, 2001
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptorH M Sarau, J A Feild, R S Ames, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Journal of Medicinal Chemistry|May 18, 2001
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonistsF E Blaney, L F Raveglia, M Artico, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonistH M Sarau, D E Griswold, B Bush, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Molecular Pharmacology|September 25, 1999
Endothelin B receptor modulates inflammatory pain and cutaneous inflammationD E Griswold, S A Douglas, L D Martin, et al.
European Journal of Pharmacology|February 28, 2001
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptorH M Sarau, J A Feild, R S Ames, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Journal of Medicinal Chemistry|May 18, 2001
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonistsF E Blaney, L F Raveglia, M Artico, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonistH M Sarau, D E Griswold, B Bush, et al.
Pageof 3